Clinical trial
Evaluation of Microcirculatory Protection In Percutaneous REvascularisation With Bioresorbable Vascular Scaffolds Versus Metallic Drug-eluting Stents: a Device- and Implant Technique-based Comparison
NCT03076476 is registered in ClinicalTrials.gov with Papworth Hospital NHS Foundation Trust as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of Microcirculatory Protection In Percutaneous REvascularisation With Bioresorbable Vascular Scaffolds Versus Metallic Drug-eluting Stents: a Device- and Implant Technique-based Comparison
- Lead sponsor
- Papworth Hospital NHS Foundation Trust
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- February 1, 2017
- Completion date
- March 10, 2021
- Enrollment
- 36 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
angina, stable, chd - coronary heart disease, myocardial ischemia